Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?: Difference between revisions
No edit summary |
mNo edit summary |
||
| Line 5: | Line 5: | ||
College of Medicine<br /> | College of Medicine<br /> | ||
University of the Philippines - Manila<br /><br /> | University of the Philippines - Manila<br /><br /> | ||
[[Image:Dec10_Colloquium-F1.png| | [[Image:Dec10_Colloquium-F1.png|500px|right]] | ||
Webpage shortcut: '''[http://goo.gl/xszDH goo.gl/xszDH]''' | Webpage shortcut: '''[http://goo.gl/xszDH goo.gl/xszDH]''' | ||
<br /><br /> | <br /><br /> | ||
Revision as of 23:32, 26 October 2012
An ELSI Colloquium on "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
10 December 2012 (Monday), 2pm
Buenafe Hall
College of Medicine
University of the Philippines - Manila

Webpage shortcut: goo.gl/xszDH
Online Registration
Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA
Organizers
- PGC ELSI Program
- UP Manila Research Ethics Review Board
See Also
“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center